According to a
report published by Grand View Research, Inc.; the global blood
preparation market is estimated to value USD 58.69 billion by 2022. Increasing
cases of diseases, accidents, and surgeries requiring blood and its components
are anticipated to propel global market in the forthcoming years. Timely
availability of appropriate blood can save life of many patients in need. This
factor is projected to create growth opportunities for the global market over
the forecast period (2018 to 2025).
Increasing cases
of blood transfusion owing to rising number of patients in emergency
departments of hospitals can impel growth of the market. Growing health
awareness among patients and introduction of novel technology are anticipated
to boost market expansion. Government initiatives to increase the number of
blood donations through reimbursement policies is expected to fuel the market. Rising
number of geriatric population coupled with increasing healthcare expenditures
can positively influence the market during the forecast period.
The worldwide blood
preparation market can be partitioned on the basis of product, application, and
region. Based on product, the market can be divided into blood components,
whole blood, and blood derivatives. In 2016, whole blood segment accounted for the
maximum market share owing to high demand for major surgeries, transfusions,
accidents. In addition, properties such as low cost, easy availability, and low
maintenance can impel its demand over the forecast period.
Browse full research report on Blood Preparation Market: https://www.grandviewresearch.com/industry-analysis/blood-preparation-market
On the other hand,
the blood derivatives segment is predicted to emerge as the fastest growing
segment in near future owing to government initiatives regarding development of
plasma derived proteins such as human fibrin foam, immunoglobulins, and dried
human plasma. Blood derivatives such as hyperimmune and intravenous
immunoglobulin can be given to patients with weak immune system or in case of
life threatening infections such as Ebola.
Based on
application, the blood preparation market can be classified into renal
impairment, pulmonary embolism, thrombocytosis, angina blood vessel
complications and others. In the coming years, angina blood vessel
complications segment is expected to grow at the fastest CAGR owing to high
prevalence of cardiovascular disorders. In addition, growing R&D for
development of anticoagulants for cardiac problems can drive market growth.
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/healthcare
Blood preparation
can also be used wisely in case of thrombocytosis. Under this condition patient
is likely to suffer from high blood platelet count, which can lead to
coagulation of blood in the circulatory system. In such situation, patient can
face life threating heart conditions. Thrombocytosis can be further bifurcated
into primary and secondary. Primary thrombocytosis is likely to be uncommon and
can exist in 24 people per million globally. Women below 40 years of age and
middle aged people can suffer from this disorder. On the other hand, secondary
thrombocytosis is expected to be common owing to its conditions such as hemorrhage,
asplenia, hyposplenism, splenectomy, osteosarcoma, and rheumatoid arthritis.
Regional
segmentation includes Europe, North America, Asia Pacific, Latin America, and
Middle East and Africa. In 2016, North America dominated the market in terms of
revenue owing to high prevalence of cardiovascular diseases and blood cancer in
the region. In addition, increasing healthcare expenditures due to rising
awareness among patients is likely to stimulate growth of the regional market
for blood preparation.
In Asia Pacific,
the market is anticipated to witness maximum growth in the coming years owing
to economic development and improving healthcare infrastructure. In addition,
increasing initiatives by public and private organizations coupled with
presence of untapped opportunities can boost the market in the forthcoming
years. The Japanese society of blood transfusion (JSBT) and the Japanese Red
Cross Society (JRCS) regulate the demand and supply of blood in Japan. Such
societies are expected to review preclinical and clinical data on blood pathogen
reduction in the country. The country is expected to depend on imports from
other countries.
Some of the
leading companies in the worldwide blood preparation market are AstraZeneca
Co.; Celgene Corp; Pfizer Inc.; Bristol-Myers Squibb Co.; and Baxter Healthcare
Corp. Most of these companies are likely to be involved in strategies such as
mergers and acquisitions, new product developments, and collaborations to
increase their market share.
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment